2015
DOI: 10.1016/j.ejphar.2014.11.045
|View full text |Cite
|
Sign up to set email alerts
|

The many different faces of major depression: It is time for personalized medicine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
24
0
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 46 publications
(27 citation statements)
references
References 207 publications
2
24
0
1
Order By: Relevance
“…The observed hippocampal reduction in GluA2 expression within long-thin and mushroom spines, along with a concomitant increase in TH and DAT represents potential dysfunction associated with mood-related illnesses, such as depression (Korte et al., 2015, Lodge and Grace, 2011). Antidepressants have been found to rescue AMPA dysfunction in chronically stressed animals (Kallarackal et al., 2013) and further increase AMPA phosphorylation and surface expression (Martinez-Turrillas et al., 2002, Svenningsson et al., 2002).…”
Section: Discussionmentioning
confidence: 99%
“…The observed hippocampal reduction in GluA2 expression within long-thin and mushroom spines, along with a concomitant increase in TH and DAT represents potential dysfunction associated with mood-related illnesses, such as depression (Korte et al., 2015, Lodge and Grace, 2011). Antidepressants have been found to rescue AMPA dysfunction in chronically stressed animals (Kallarackal et al., 2013) and further increase AMPA phosphorylation and surface expression (Martinez-Turrillas et al., 2002, Svenningsson et al., 2002).…”
Section: Discussionmentioning
confidence: 99%
“…Following the introduction of the selective serotonin reuptake inhibitors (SSRI), hypotheses emerged that altering serotonergic neurotransmission, via the transmitter and/or its receptors, made them more “selective” for MDD or specific MDD subtypes [10]. With the advent of serotonin-norepinephrine reuptake inhibitors and triple (serotonin, norepinephrine, dopamine) reuptake inhibitors [11], manufacturers speculated that such “broad-spectrum” actions made these antidepressants preferable for certain depressed patients [12]. …”
Section: What Is the Therapeutic Action Of Antidepressants?mentioning
confidence: 99%
“…This neurobiology forms the basis for the action of important pharmaceuticals, including synthetic PAA derivatives such as the antidepressant bupropion (e.g. Wellbutrin) (2) and amphetamine-containing attention deficit disorder treatments (e.g. Adderall and Dexedrine) (3).…”
mentioning
confidence: 99%